Abstract:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still an ongoing global health crisis. Immediately after the inhalation of SARS-CoV-2 viral particles, alveolar type II epithelial cells harbor and initiate local innate immunity. These particles can infect circulating macrophages, which then present the coronavirus antigens to T cells. Subsequently, the activation and differentiation of various types of T cells, as well as uncontrollable cytokine release (also known as cytokine storms), result in tissue destruction and amplification of the immune response. Vitamin D enhances the innate immunity required for combating COVID-19 by activating toll-like receptor 2. It also enhances antimicrobial peptide synthesis, such as through the promotion of the expression and secretion of cathelicidin and β-defensin; promotes autophagy through autophagosome formation; and increases the synthesis of lysosomal degradation enzymes within macrophages. Regarding adaptive immunity, vitamin D enhances CD4+ T cells, suppresses T helper 17 cells, and promotes the production of virus-specific antibodies by activating T cell-dependent B cells. Moreover, vitamin D attenuates the release of pro-inflammatory cytokines by CD4+ T cells through nuclear factor κB signaling, thereby inhibiting the development of a cytokine storm. SARS-CoV-2 enters cells after its spike proteins are bound to angiotensin-converting enzyme 2 (ACE2) receptors. Vitamin D increases the bioavailability and expression of ACE2, which may be responsible for trapping and inactivating the virus. Activation of the renin–angiotensin–aldosterone system (RAS) is responsible for tissue destruction, inflammation, and organ failure related to SARS-CoV-2. Vitamin D inhibits renin expression and serves as a negative RAS regulator. In conclusion, vitamin D defends the body against SARS-CoV-2 through a novel complex mechanism that operates through interactions between the activation of both innate and adaptive immunity, ACE2 expression, and inhibition of the RAS system. Multiple observation studies have shown that serum concentrations of 25 hydroxyvitamin D are inversely correlated with the incidence or severity of COVID-19. The evidence gathered thus far, generally meets Hill’s causality criteria in a biological system, although experimental verification is not sufficient. We speculated that adequate vitamin D supplementation may be essential for mitigating the progression and severity of COVID-19. Future studies are warranted to determine the dosage and effectiveness of vitamin D supplementation among different populations of individuals with COVID-19.

The Effects of Vitamin D on Immune System and Inflammatory Diseases

Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory

Immune Modulatory Effects of Vitamin D on Viral Infections

Immunologic Effects of Vitamin D on Human Health and Disease

Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19

Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review

ASSOCIATION OF VITAMIN D DEFICIENCY TO SEVERITY OF COVID-19 : A SYSTEMATIC REVIEW

Role of vitamin D in COVID-19 and other viral infections

Vitamin D in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects

The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis

Vitamin D Regulation of Immune Function

Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants

The Role of Vitamin D in Reducing SARS-CoV-2 Infection: an Update

Vitamin D and the Pathogenesis of Inflammatory Bowel Disease

Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D

Extra-Skeletal Effects of Vitamin D

Vitamin D’s Effect on Immune Function

Regulation of Dendritic Cell Function by Vitamin D

Vitamin D in the prevention or treatment of COVID-19

[Association between vitamin D and inflammatory bowel diseases]

Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review